Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_50eb752940fa4aa36756a6bc9f6f3504 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-577 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2866 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
filingDate |
2014-06-03^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2019-08-27^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71e8bc575a50e2e40d5fbcaac5f3317e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_973ff7ce33b9c5f730a90445e1a94cfb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9c8162a86477f4b7ff2a52831bcb808 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aacb98a076cfc796191af8e2e41c0d5b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6618bb3c0fbf249dc00dbe965f64a328 |
publicationDate |
2019-08-27^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-10392439-B2 |
titleOfInvention |
Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R inhibitor |
abstract |
The present invention provides methods for treating, preventing or reducing the severity of allergic reactions. The present invention also provides methods for enhancing the efficacy and/or safety of an allergen-specific immunotherapy (SIT) regimen. The methods of the present invention comprise administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4Rα) antagonist such as an anti-IL-4Rα antibody. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11771743-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11167004-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11053309-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10676530-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11504426-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018179288-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11485788-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021119028-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11421036-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11603408-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11292847-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018094070-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3992974-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11723974-B2 |
priorityDate |
2013-06-04^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |